Edition:
India

CannTrust Holdings Inc (TRST.TO)

TRST.TO on Toronto Stock Exchange

1.42CAD
27 Jan 2020
Change (% chg)

-- (--)
Prev Close
$1.42
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
868,117
52-wk High
$13.48
52-wk Low
$0.99

Summary

Name Age Since Current Position

Eric Paul

78 2018 Chairman of the Board, Director

Robert Marcovitch

62 2019 Interim Chief Executive Officer, Director

Peter Aceto

2018 Chief Executive Officer

Mark Litwin

56 2018 Independent Vice Chairman

Greg Guyatt

2019 Chief Financial Officer

Len Walt

2019 Chief Medical Officer

Stan Abramowitz

2015 Secretary

Mitchell Sanders

58 2015 Director

Mark Dawber

80 2017 Independent Director

Shawna Page

54 2018 Independent Director

Marc Charbin

IR Contact Officer

Biographies

Name Description

Eric Paul

Mr. Eric Paul is Chairman of the Company. He was Chief Executive Officer of the Company ending on October 1, 2018. He is a pharmacist and has been a senior business executive with over 40 years in the healthcare industry including MediTrust, Canada's first mail order pharmacy, a hospital medication management software system company and President of one of Canada's largest discount retailers.

Robert Marcovitch

Mr. Robert F. Marcovitch is Interim Chief Executive Officer, Director of the Company. He is a seasoned chief executive with substantial business experience, managing companies with in excess of $1 billion dollars in revenue. He was until recently the President and CEO of K2 Ski's, an international developer, manufacturer, marketer and distributor of winter sports equipment and held that position since October 2015 (and was previously with K2 from 1999 to 2011). His responsibilities included managing factories in Europe and the USA. He was previously the Chief Executive Officer at The Coleman Outdoor Company from 2011 until 2015, and prior to that, was Chief Executive Officer and President of Ride, Inc. from 1994 to 1999, which prior to its acquisition by K2 was a large publicly traded company.

Peter Aceto

Mr. Peter Aceto is Chief Executive Officer of the Company from October 1, 2018. Previously, Mr. Aceto served for ten years as President and Chief Executive Officer of Tangerine Bank (formerly, ING Direct). Prior to that, he held the positions of Chief Risk Officer, Chief of Staff and Chief Lending Officer at ING Direct in the U.S., and was legal and general counsel at ING Direct in Canada.

Mark Litwin

Mr. Mark I. Litwin is Independent Vice Chairman of the Company. He is the President of Gencan Capital Inc., a CSE-listed corporation. Mr. Litwin was previously President and a Director of Gencan's predecessor corporations which were listed on the TSXV and TSX. He is also President of Sutton Management Limited, an investment and management holding company. Mr. Litwin has held the position of President and has been a director of a number of public companies. He has significant experience in the real estate industry and has a B.Econ (Hons) and MBA degrees from York University. Mr. Litwin is a member of the board of the UHN Toronto Rehab Hospital Foundation and the Mt Sinai Hospital Finance/Resource Committee.

Greg Guyatt

Mr. Greg Guyatt has been appointed as a Chief Financial Officer of the company, effective February 19, 2019. he comes to CannTrust from GreenSpace Brands Inc. (TSXV:JTR), a Canadian-based premium natural food product company, where he served as CFO. He brings more than 20 years of experience building high-performing finance teams from the consumer packaged goods, pharmaceutical and private equity sectors. Greg began his career with Deloitte.

Len Walt

Dr. Len Walt is Chief Medical Officer of the company. Dr. Walt comes to CannTrust with extensive senior leadership experience in the pharmaceutical and biotechnology industries in Canada, USA and abroad. Most recently Dr. Walt held the position of Vice President and Head of Medical Affairs at Sobi Inc., where he led their North American medical and scientific operations. Previously, Dr. Walt held the position of Medical Director at Biogen Canada where he built best-in-class medical teams and developed strong relationships with key clinical investigators in Canada.

Stan Abramowitz

Mr. Stan Abramowitz is Secretary of the Company. He is a CPA and Chartered Accountant with over 30 years of practice and financial experience in Canada and South Africa. He is the Chief Financial Officer and Secretary of Forum, positions he has held since 1989. Forum is a Toronto based merchant banking group. Through his affiliation with Forum, Mr. Abramowitz has also held the positions of Chief Financial Officer, Secretary and Director of a number of public companies listed on the TSX and TSXV. Mr. Abramowitz is currently the Chief Financial Officer and a Director of Gencan Capital a CSE-listed corporation. Prior to 1989, Mr. Abramowitz worked in the accounting profession. He has a B.Acc and a B.Com degree from the University of the Witwatersrand, South Africa.

Mitchell Sanders

Mr. Mitchell J. Sanders is Director of the Company. He is a senior partner at Goldman, Spring, Kichler & Sanders LLP since 1990, providing services in the areas of corporate finance, mergers and acquisitions, and securities law to mid-market clients in both Canada and the United States. He has been counsel in numerous public and private financing transactions, initial public offerings, and private placements throughout North America and currently sits on the boards and advisory committees of various companies and not-for-profit entities. He is a former long-time member of The Executive Committee (TEC), an international organization of Chief Executive Officer's, as well as a former member of the Small Business Advisory Committee to the Ontario Securities Commission, and a current member of the board of the UHN Toronto Rehab Hospital Foundation.

Mark Dawber

Mr. Mark E. Dawber is Independent Director of the Company. He is a CPA and Chartered Accountant with significant public accounting experience having been an Audit Partner at Moore Stephens Hyde Houghton from 1971 until 1998 and BDO Canada LLP from 1999 to 2000. He has extensive public company experience having served on public company boards for many years as an independent director, chair of audit committees and as a member of governance and compensation committees. He has conducted numerous assignments for the Institute of Chartered Accountants of Ontario's Professional Conduct Committee.

Shawna Page

Ms. Shawna Page is Independent Director of the Company. She brings years of experience in both the capital markets, as well as the consumer retail markets. Ms. Page spent 10 years working at Merrill Lynch Canada, followed by 10 years at TD Securities where she was Managing Director and Chief of Staff. In 2007, Ms. Page launched a unique mass-channel brand of gender-specific and condition-specific nutraceuticals across Canada, and later in various international markets, which she successfully exited in November 2016. Ms. Page has a Bachelor of Science degree from the University of Toronto and a Financial Markets Certification from Yale University.

Marc Charbin

Basic Compensation

Name Fiscal Year Total

Eric Paul

768,923

Robert Marcovitch

305,000

Peter Aceto

8,251,630

Mark Litwin

305,000

Greg Guyatt

--

Len Walt

--

Stan Abramowitz

--

Mitchell Sanders

285,000

Mark Dawber

310,000

Shawna Page

290,805

Marc Charbin

--
As Of  31 Dec 2018